Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy

PARSIPPANY, N.J.--(BUSINESS WIRE)--Iveric Bio announced positive topline results from GATHER2, the Company’s second Phase 3 clinical trial of Zimura, for the treatment of GA.